Efficacy of prophylactic clipping for postpolypectomy bleeding: A multicenter randomized controlled trial

Efficacy of prophylactic clipping for postpolypectomy bleeding: A multicenter randomized controlled trial - Efficacy of prophylactic clipping for postpolypectomy bleeding

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012163

Enrollment

1080

Registered

2013-10-30

Start date

2013-12-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal neoplasms

Interventions

Colonoscopic polypectomy Prophylactic clipping after colonoscopic polypectomy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with colorectal neoplasms considered an indication for colonoscopic polypectomy

Exclusion criteria

Exclusion criteria: Age under 20 years old. Lesions larger than 20mm in diameter. Lesions considered an indication for endoscopic submucosal dissection. Poor condition (PS 2 or 3). Continuous anticoagulant therapy (heparin bridge therapy). Patients with principal organ dysfunction. Patients disagree with the present clinical trial.

Design outcomes

Primary

Measure	Time frame
Postpolypectomy bleeding rate	—

Countries

Japan

Contacts

Public ContactMasahiko Tsujii

Osaka University Graduate School of Medicine Department of Gastroenterology and Hepatology

mt@gh.med.osaka-u.ac.jp06-6879-3621

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026